COMMUNIQUÉS West-GlobeNewswire

-
Baylor Genetics to Showcase Genetic Testing Innovations for Rare Disease at ACMG 2025 Annual Clinical Genetics Meeting
11/03/2025 - 15:00 -
Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025
11/03/2025 - 15:00 -
Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025
11/03/2025 - 16:00 -
OSE Immunotherapeutics et le GERCOR annoncent des premiers résultats cliniques positifs de OSE2101 (Tedopi®) dans l’essai clinique de Phase 2 TEDOPaM dans le cancer du pancréas avancé
11/03/2025 - 18:00 -
OSE Immunotherapeutics and GERCOR Announce Positive Topline Phase 2 Result for Clinical Trial TEDOPaM Evaluating OSE2101 (Tedopi®) in Advanced Pancreatic Cancer
11/03/2025 - 18:00 -
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 28 février 2025
11/03/2025 - 18:00 -
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2025
11/03/2025 - 18:00 -
Nymox Announces Dismissal of Delaware Action Against Ascella
11/03/2025 - 18:51 -
Tilray Medical lance Tilray Craft et introduit des variétés génétiques à forte teneur en THC et en terpènes sur le marché allemand du cannabis thérapeutique
11/03/2025 - 19:12 -
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results
11/03/2025 - 21:01 -
Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
11/03/2025 - 21:01 -
Mural Oncology Announces Fourth Quarter and Year End 2024 Financial Results and Highlights Upcoming Clinical Milestones
11/03/2025 - 21:01 -
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
11/03/2025 - 21:05 -
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2024
11/03/2025 - 21:05 -
MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance
11/03/2025 - 21:05 -
Sanara MedTech to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025
11/03/2025 - 21:05 -
Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2024
11/03/2025 - 21:05 -
MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance
11/03/2025 - 21:05 -
Zevra Reports Full Year 2024 and Fourth Quarter Financial Results
11/03/2025 - 21:05
Pages